» Articles » PMID: 34622312

Post-COVID Fungal Infections of Maxillofacial Region: a Systematic Review

Overview
Date 2021 Oct 8
PMID 34622312
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

With the advent of coronavirus disease (COVID-19) pandemic, a wide range of life-threatening maxillofacial fungal coinfections have also been observed in patients. We conducted this systematic review to collate and evaluate the data to enable clinicians to understand the disease pattern and types of mycosis and provide meticulous management of these infections in COVID-19 patients. The review was carried out in accordance with Preferred Reporting Items for Systematic Review and Meta-analysis guidelines. A systematic electronic literature search was conducted on major databases using keywords in combination with Boolean Operators. Manuscripts discussing cases of maxillofacial fungal infections in COVID-19 patients were included. A total of 11 studies were systematically reviewed to assess the fungal coinfections in COVID-19 patients. Twenty-one cases of mucormycosis, 58 of candidiasis, and 1 each of aspergillosis and mixed infection were observed in the region of head and neck. Significant increase in invasive fungal infection is evident in patients suffering from COVID-19 which could be due to immunosuppression and other pre-existing comorbidities. Early diagnosis and intervention like systemic antifungals or surgical debridement is mandatory to reduce morbidity and mortality.

Citing Articles

[Candida albicans: risk factor in covid-19 patients].

San Martin Andrade D, Cardenas Amendano C, Solorzano Cuenca A, Ulloa Pacheco J, Medina-Sotomayor P Rev Cient Odontol (Lima). 2024; 10(4):e132.

PMID: 38390607 PMC: 10880693. DOI: 10.21142/2523-2754-1004-2022-132.


Reactivated herpetic gingivostomatitis with secondary herpes-associated erythema multiforme and oral candidiasis post-COVID infection: A case report.

Lee H, Davoudi J, Vistoso A, Khalifeh M, Sedghizadeh P Clin Case Rep. 2023; 11(4):e7175.

PMID: 37006852 PMC: 10064031. DOI: 10.1002/ccr3.7175.


Molecular Mapping of Antifungal Mechanisms Accessing Biomaterials and New Agents to Target Oral Candidiasis.

Anuta V, Talianu M, Dinu-Pirvu C, Ghica M, Prisada R, Albu Kaya M Int J Mol Sci. 2022; 23(14).

PMID: 35886869 PMC: 9320712. DOI: 10.3390/ijms23147520.


Alternate Special Stains for the Detection of Mycotic Organisms in Oral Cyto-Smears-A Histomorphometric Study.

Sowmya S, Augustine D, Hemanth B, Prathab A, Alamoudi A, Bahammam H Microorganisms. 2022; 10(6).

PMID: 35744745 PMC: 9229114. DOI: 10.3390/microorganisms10061226.


COVID-19 and Fungal Diseases.

Oh K, Lee S Antibiotics (Basel). 2022; 11(6).

PMID: 35740209 PMC: 9219667. DOI: 10.3390/antibiotics11060803.


References
1.
Mahase E . China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ. 2020; 368:m408. DOI: 10.1136/bmj.m408. View

2.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

3.
Reddy S, Nair N, Tate J, Thiyagarajan V, Giri S, Praharaj I . Intussusception after Rotavirus Vaccine Introduction in India. N Engl J Med. 2020; 383(20):1932-1940. PMC: 7492078. DOI: 10.1056/NEJMoa2002276. View

4.
Peman J, Ruiz-Gaitan A, Garcia-Vidal C, Salavert M, Ramirez P, Puchades F . Fungal co-infection in COVID-19 patients: Should we be concerned?. Rev Iberoam Micol. 2020; 37(2):41-46. PMC: 7489924. DOI: 10.1016/j.riam.2020.07.001. View

5.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View